CBChristin Berjaoui

Christin Berjaoui

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Christin Berjaoui has a total of 88 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Late fatal deterioration of supra- and infratentorial acute epidural hematoma in a 13-year-old: case report and literature review

    by Christin Berjaoui, Zeinab Nahle, Ali Akil, Joseph Mantoura, Paul Hage

    Introduction: Supra- and infratentorial epidural hematomas are rare, representing only 2% of traumatic, cases. They often remain clinically silent or present with nonspecific symptoms but carry a risk of delayed yet rapidly fatal deterioration and life-threatening foramen magnum herniation. Case summary: A previously healthy 13-year-old male presented following sports-related head trauma with a 2-minute loss of consciousness, frontal headaches, and vomiting. Brain computed tomography (CT) revealed a right parieto-occipital supra- and infratentorial epidural hematoma with a volume of 27.6 cm 3 for the supratentorial component and 9.3 cm 3 for the infratentorial component, as well as a minimal 3 mm left-sided midline shift. He remained asymptomatic for 5 days with stable hematoma volume. On day 6, he experienced rapid neurological deterioration; repeat CT showed hematoma expansion. Urgent craniectomy for decompression was performed. Postoperatively, he was transferred, intubated, to the intensive care unit with a Glasgow Coma Scale of 3 T and nonreactive miotic pupils. Within hours, he developed hypotension and died from brain herniation. Clinical discussion: Simultaneous supra- and infratentorial epidural hematoma is an exceptionally rare injury that may remain clinically silent despite the potential for catastrophic delayed deterioration. This case demonstrates that fatal hematoma expansion can occur beyond the typical 24–48-hour window, highlighting the limitations of relying solely on neurological stability and the importance of vigilant radiological surveillance. Conclusion: This case highlights the potential for delayed, rapidly fatal deterioration in supratentorial and infratentorial epidural hematomas. Vigilant monitoring and timely intervention are essential. Because of the rarity and unpredictability of supra- and infratentorial epidural hematoma, further studies are needed to guide optimal management.

  • Open Access

    Reversible cerebral vasoconstriction syndrome as a rare postoperative complication after resection of a rosette-forming glioneuronal tumor: a case report and literature review

    by Ali Akil, Christin Berjaoui, Hussein Akil, Selim Nasser, Ibrahim Saikali

    Introduction: Reversible cerebral vasoconstriction syndrome (RCVS) is an uncommon postoperative complication, rarely reported after posterior fossa tumor resections. Rosette-forming glioneuronal tumor (RGNT) is an infrequent, low-grade neoplasm of the central nervous system. To our knowledge, no prior cases of RCVS following RGNT resection have been documented. Case summary: We report a male patient in his 20s who underwent suboccipital craniotomy for resection of a cerebellar RGNT. Three weeks postoperatively, the patient presented with acute right hemiparesis and aphasia. Brain MRI demonstrated a left hemisphere watershed ischemic lesion. Magnetic resonance angiography revealed narrowing and “beading” of major intracranial arteries bilaterally, consistent with RCVS. Management included therapeutic anticoagulation, dual antiplatelet therapy, and intravenous hydration. The patient achieved complete neurological recovery. Clinical discussion: RCVS is characterized by transient, reversible multifocal cerebral arterial vasoconstriction and is associated with vasoactive triggers and surgical stress. Postoperative RCVS is rare after posterior fossa surgery, and differentiation from primary angiitis of the CNS and thromboembolic stroke is essential. Proposed mechanisms include endothelial dysfunction, surgical manipulation, and hemodynamic changes. Conclusion: RCVS can manifest as a delayed complication after posterior fossa tumor resection; Prompt diagnosis and supportive management are essential for recovery.

  • Open Access

    Acute fulminant cerebellitis in children: a case series and literature review on diagnostic challenges and management strategies

    by Ali Akil, Christin Berjaoui, Hussein Akil, Ibrahim Saikali

    Background: Acute cerebellitis (AC) in children is often benign; however, a fulminant variant featuring rapid cerebellar edema, hydrocephalus, and brainstem compression can be life-threatening. Case summary: We present a three-case series of pediatric patients with fulminant cerebellitis. The first patient, a 12-year-old female, experienced rapid neurological decline despite initial corticosteroid therapy and underwent emergent posterior fossa decompression, resulting in full neurological recovery. The second patient, a 2-year-old female, presented with obstructive hydrocephalus, initially misdiagnosed as a posterior fossa neoplasm; despite high-dose corticosteroids and delayed external ventricular drainage (EVD), she progressed to brainstem failure and succumbed. The third patient, a 10-year-old male, was treated with urgent EVD insertion, high-dose corticosteroids, and intensive care monitoring, achieving rapid clinical improvement and complete recovery. Conclusion: Fulminant AC in children, although rare, carries a high risk of morbidity and mortality. Prompt recognition and aggressive management, including high-dose corticosteroids, cerebrospinal fluid diversion, and timely posterior fossa decompression when needed, can substantially reduce morbidity and mortality in fulminant cerebellitis.

  • Open Access

    Surgical management of congenital pouch colon in Lebanon: A case report and review of the literature

    by Amal Naous, Christin Berjaoui, Malek Osta, Amar Hafez, Khaldoun Sinno


  • Open Access

    Mycoplasma Pneumonia Complicated by Stevens-Johnson Syndrome: A case report

    by Jida Hasbini, Nour Safawi, Christin Berjaoui, Mariam Rajab, Amal Naous


  • Open Access

    Neuroinflammation-on-a-chip for multiple sclerosis research: a narrative review

    by Christin Berjaoui, Charbel Kachouh, Safaa Joumaa, Mohammad Hussein Ghayyad, Bisrat Abate Bekele, Rita Ajirenike, Zeina Al Maaz, Sara Awde, Magda Wojtara, Abubakar Nazir, et al.

    Introduction: Multiple sclerosis (MS) is a chronic inflammatory condition that impacts the central nervous system. It is distinguished by processes like demyelination, gliosis, neuro-axonal harm, and inflammation. The prevailing theory suggests that MS originates from an immune response directed against the body’s own antigens within the central nervous system. Aim: The main aim of this research paper “Neuroinflammation-on-a-Chip” for studying multiple sclerosis is to enhance our comprehension of MS development, demonstrate the application of cutting-edge technology, and potentially provide valuable insights for therapeutic approaches. Methods: The available literature for this Narrative Review was searched on various bibliographic databases, PubMed, NCBI, and many other medical references using an individually verified, prespecified approach. Studies regarding the significance of MS and its neuroinflammatory pathogenesis in addition to the development and optimization of neuroinflammatory-on-a-chip and the advancement in innovations in this field have been reviewed in this research for a better understanding of “Neuroinflammation-on-a-chip for multiple sclerosis”. The level of evidence of the included studies was considered as per the Centre for Evidence-Based Medicine recommendations. Results: Several studies have indicated that the brain-chip model closely mimics cortical brain tissue compared to commonly used conventional cell culture methods like the Transwell culture system. Additionally, these studies have clearly demonstrated that further research using brain chips has the potential to enhance our understanding of the molecular mechanisms and roles of blood-brain barrier (BBB) transporters in both normal and disease conditions. Conclusion: Understanding neuroinflammation processes remains essential to establish new MS treatments approaches. The utilization of brain chips promises to advance our understanding of the molecular processes involving BBB transporters, both in normal and diseased states. Further research needs to be addressed in order to enhance the performance and understanding of neuroinflammation on a chip, hence aiming to provide more effective treatments for all CNS diseases.


  • Open Access

    Epidemiology and clinical characteristics of headache among COVID-19 patients in Lebanon: a retrospective cohort study

    by Nour Safawi, Jida Hasbini, Hawaa Khodor, Salim Atrouni, Christin Berjaoui, Hania ElJarkass

    Background: With the spread and rise in the number of infections of COVID-19 globally, patients experienced neurologic manifestations such as headache and dizziness, along with other serious medical conditions such as stroke and seizures. Many reported cases highlighted headache to be one of the most common COVID-19-related neurological symptoms. With the evolution of the pandemic, broad studies are needed to better understand the mechanism of headache with COVID-19. The aim of this study is to recognize the epidemiology, characteristic and progression of headache among patients with COVID-19 in Lebanon. Methods: A retrospective cohort study was done to assess 439 patients for headache during the course of COVID-19. The Statistical Package for Social Sciences (SPSS) version 26 was used for descriptive analysis. Results: A confirmed COVID-19 Infection by PCR test was confirmed among 86% of the participants. Tension-like headache was the most common type of headache experienced by participants during COVID-19. Pain was mainly diffuse (48.7%), and compressing in nature (77.0%). Moreover, about 29% required a physician consultation and 7.7% had emergency visits. Partial relief by analgesics was reported in 54.9%, and mainly by paracetamol (64.6%). Those who reported having a history of primary headache before contracting COVID-19 were 46.7%. Among them, 36.7% patients reported a change in the type of headache and about 49.6% reported increased severity. Conclusion: Headache accompanied with COVID-19 is a common symptom during the early stages of illness. COVID-19 related headache was characterized as mainly involving the whole head region, pressuring, and partially relieved by analgesics. Thus, headache should raise early concern for the probability of being infected by COVID-19.


  • Open Access

    Unveiling the sleep‐cardiovascular connection: Novel perspectives and interventions—A narrative review

    by Christin Berjaoui, Bethlehem Tesfasilassie Kibrom, Mohammad Ghayyad, Safaa Joumaa, Nihal Talal Al Labban, Abubakar Nazir, Charbel Kachouh, Abdulrahmon Akanmu Moradeyo, Magda Wojtara, Olivier Uwishema

    Introduction: Sleep is an important neurophysiological condition that is intricately linked to general health, laying the basis for both physiological and psychological well‐being. A thorough examination of sleep disorders and cardiovascular health demonstrates their deep relationship, emphasizing the numerous diagnostic tools and treatment techniques available.Aim: This study aims to examine the impact, mechanisms, diagnostic techniques, treatment strategies, implications, and healthcare interventions of the sleep‐cardiovascular connection, to better understand the relationship between sleep disorders and cardiovascular health.Methods: The paper reviews key studies conducted from 2015‐till date, investigating the impact of sleep disorders on the cardiovascular system. It looked into data relating to cardiovascular outcomes based on the degree of sleep disorders, considered potential confounding factors, and addressed current research constraints.Results: The findings highlight a strong link between sleep problems and poor cardiovascular outcomes. Emerging diagnostic tools, such as enhanced sleep‐related technology and biomarkers, open up new avenues for determining the impact of sleep disturbances on cardiovascular health. In addition, the research discusses several treatment options, ranging from cognitive behavioral therapy to pharmaceutical therapies, and their potential benefits in addressing sleep‐related cardiovascular risks.Conclusion: The complex association between sleep disturbances and cardiovascular health emphasizes the need to recognize sleep as a critical component of overall well‐being. Thus collaboration among medical disciplines, as well as individualized therapies, are critical to improving patient care. Moreover, Understanding and managing the consequences of sleep problems on cardiovascular health can lead to more effective interventions, better outcomes, and improved public health as research advances.